Unlock instant, AI-driven research and patent intelligence for your innovation.

Cell strain of monoclonal antibody against ciprofloxacin and monoclonal antibody thereof

A monoclonal antibody, ciprofloxacin technology, applied in the field of bioengineering, can solve the problems of high cost, long time consumption, sensitivity not meeting national standards, etc., and achieve the effects of cost saving, strong specificity and high sensitivity

Inactive Publication Date: 2012-01-04
SHANGHAI OCEAN UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among them, although the requirements of microbiological method are not high, the sensitivity of detection cannot meet the national standard.
Although high-performance liquid chromatography and capillary electrophoresis have high sensitivity and can carry out large-scale detection, they take a long time and the cost of purchasing equipment is also very high, generally more than 300,000 yuan

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cell strain of monoclonal antibody against ciprofloxacin and monoclonal antibody thereof
  • Cell strain of monoclonal antibody against ciprofloxacin and monoclonal antibody thereof
  • Cell strain of monoclonal antibody against ciprofloxacin and monoclonal antibody thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Example 1: Preparation of ImmunogenCiprofloxacin and Bovine Serum Albumin Conjugate (CIP-BSA)

[0033] 1. Weigh 8.5g of sodium chloride, 2.85g of disodium hydrogen phosphate, 0.2g of potassium chloride, 0.27g of potassium dihydrogen phosphate, add 950mL of distilled water, add hydrochloric acid dropwise to adjust the pH to 5.0, and then add 50mL of Distilled water, configured as 1000mL phosphate buffer solution with a concentration of 0.01mol / L.

[0034] 2. Weigh 40 mg of bovine serum albumin and add 5 mL of phosphate buffer (pH 5.0, content 0.01 mol / L) to make 8 mg / mL (0.12 μmol / L) bovine serum albumin aqueous solution.

[0035] 3. Weigh 100 mg of ciprofloxacin and add 5 mL of phosphate buffer (pH 5.0, content 0.01 mol / L) to make 20 mg / mL (60.4 μmol / L) ciprofloxacin aqueous solution.

[0036] 4. Weigh 960 mg of carbodiimide and add 4 mL of phosphate buffer (pH 5.0, content 0.01 mol / L) to make an aqueous solution of 240 mg / mL (1251.9 μmol / L).

[0037] 5. Add 8mg / mL (...

Embodiment 2

[0040] Example 2: Coating source—preparation of ciprofloxacin and chicken egg serum albumin conjugate (CIP-OVA)

[0041] 1. Weigh 8.5g of sodium chloride, 2.85g of disodium hydrogen phosphate, 0.2g of potassium chloride, 0.27g of potassium dihydrogen phosphate, add 950mL of distilled water, add hydrochloric acid dropwise to adjust the pH to 5.0, and then add 50mL of Distilled water, configured as 1000mL phosphate buffer solution with a concentration of 0.01mol / L.

[0042] 2. Weigh 40 mg of chicken egg serum albumin and add 5 mL of phosphate buffer (pH 5.0, content 0.01 mol / L) to make 8 mg / mL (0.178 μmol / L) chicken egg serum albumin aqueous solution.

[0043]3. Weigh 100 mg of ciprofloxacin and add 5 mL of phosphate buffer (pH 5.0, content 0.01 mol / L) to make 20 mg / mL (60.4 μmol / L) ciprofloxacin aqueous solution.

[0044] 4. Weigh 960 mg of carbodiimide and add 4 mL of phosphate buffer (pH 5.0, content 0.01 mol / L) to make an aqueous solution of 240 mg / mL (1251.9 μmol / L).

[0...

Embodiment 3

[0048] Example 3: Preparation and purification of monoclonal antibodies

[0049] 1. Immunity

[0050] Dilute the immunogen CIP-BSA powder with phosphate buffer (pH 5.0, content 0.01mol / L) to obtain a 2 mg / mL immunogen solution, add 100 μL Freund’s complete adjuvant to 100 μL immunogen solution (2 mg / mL), After thorough mixing, 4-week-old Balb / c mice were taken and injected abdominally for immunization.

[0051] Two weeks after the immunization, take 100 μL of the immunogen solution (2 mg / mL) and add 100 μL of Freund’s incomplete adjuvant, mix thoroughly, and inject into the abdomen for immunization.

[0052] One week later, 100 μL of immunogen solution (2 mg / mL) was taken for tail vein booster immunization.

[0053] Ten days later, 50 μL of the immunogen solution (2 mg / mL) was injected into the tail vein for booster immunization.

[0054] 2. Cell Fusion

[0055] 1. Recovery and culture of myeloma cells:

[0056] 10 days before fusion, take the frozen SP2 / 0 myeloma cells o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a cell strain of a monoclonal antibody against ciprofloxacin and the monoclonal antibody thereof. The obtained monoclonal antibody can be used for preparing an enzyme-linked immuno sorbent assay (ELISA) kit for rapid detection of ciprofloxacin to realize rapid detection of the residual ciprofloxacin in the aquatic products. In the method, firstly the immunogen-ciprofloxacin and bovine serum albumin (CIP-BSA) conjugate and the coating antigen-ciprofloxacin and ovalbumin (CIP-OVA) conjugate are prepared by a carbodiimide one-step method; CIP-BSA is used for immunizing the Balb / c mice and the spleen cells of the immunized Balb / c mice and the SP2 / 0 myeloma cells are fused; positive clones are screened by indirect ELISA, and the cell strain of the monoclonal antibody against ciprofloxacin, which is stable in secretion, is obtained through multiple subcloning; and ascites is prepared by in vivo animal induction and the monoclonal antibody is obtained after purifying the ascites.

Description

Technical field: [0001] The invention belongs to the technical field of bioengineering, and relates to a ciprofloxacin monoclonal antibody cell line and the monoclonal antibody produced therefrom. Background technique: [0002] Ciprofloxacin (CIP), also known as ciprofloxacin, belongs to the third-generation fluoroquinolones. Ciprofloxacin plays a bactericidal effect by inhibiting the synthesis of bacterial DNA helicase. As a broad-spectrum antibacterial drug, ciprofloxacin has a strong bactericidal ability, so ciprofloxacin is widely used in the treatment of human and aquatic animal diseases. Since the residue of ciprofloxacin in aquatic products directly threatens public health safety, ciprofloxacin has been listed as a banned drug for aquaculture by the European Union, the United States, and China. [0003] At present, the detection methods of ciprofloxacin mainly include microbial method, high performance liquid chromatography, capillary electrophoresis and so on. The...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/20C07K14/765C07K14/77C07K1/113C12N15/06C12P21/08C07K16/44
Inventor 杨先乐黄宣运陈力姜有声胡鲲王玲喻文娟付乔芳何珊
Owner SHANGHAI OCEAN UNIV